Exact Mass: 495.1562944000001
Exact Mass Matches: 495.1562944000001
Found 76 metabolites which its exact mass value is equals to given mass value 495.1562944000001
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Sodium folinate
C20H22N7NaO7 (495.14783420000003)
V - Various > V03 - All other therapeutic products > V03A - All other therapeutic products > V03AF - Detoxifying agents for antineoplastic treatment
Nikkomycin
C20H25N5O10 (495.16013499999997)
D000890 - Anti-Infective Agents > D000935 - Antifungal Agents D004791 - Enzyme Inhibitors
Cys Cys Asp Arg
Cys Cys Arg Asp
Cys Asp Cys Arg
Cys Asp Arg Cys
Cys Gly Met Trp
C21H29N5O5S2 (495.16100240000003)
Cys Gly Trp Met
C21H29N5O5S2 (495.16100240000003)
Cys Met Gly Trp
C21H29N5O5S2 (495.16100240000003)
Cys Met Trp Gly
C21H29N5O5S2 (495.16100240000003)
Cys Arg Cys Asp
Cys Arg Asp Cys
Cys Trp Gly Met
C21H29N5O5S2 (495.16100240000003)
Cys Trp Met Gly
C21H29N5O5S2 (495.16100240000003)
Asp Cys Cys Arg
Asp Cys Arg Cys
Asp Arg Cys Cys
Gly Cys Met Trp
C21H29N5O5S2 (495.16100240000003)
Gly Cys Trp Met
C21H29N5O5S2 (495.16100240000003)
Gly Met Cys Trp
C21H29N5O5S2 (495.16100240000003)
Gly Met Trp Cys
C21H29N5O5S2 (495.16100240000003)
Gly Trp Cys Met
C21H29N5O5S2 (495.16100240000003)
Gly Trp Met Cys
C21H29N5O5S2 (495.16100240000003)
Met Cys Gly Trp
C21H29N5O5S2 (495.16100240000003)
Met Cys Trp Gly
C21H29N5O5S2 (495.16100240000003)
Met Gly Cys Trp
C21H29N5O5S2 (495.16100240000003)
Met Gly Trp Cys
C21H29N5O5S2 (495.16100240000003)
Met Trp Cys Gly
C21H29N5O5S2 (495.16100240000003)
Met Trp Gly Cys
C21H29N5O5S2 (495.16100240000003)
Arg Cys Cys Asp
Arg Cys Asp Cys
Arg Asp Cys Cys
Trp Cys Gly Met
C21H29N5O5S2 (495.16100240000003)
Trp Cys Met Gly
C21H29N5O5S2 (495.16100240000003)
Trp Gly Cys Met
C21H29N5O5S2 (495.16100240000003)
Trp Gly Met Cys
C21H29N5O5S2 (495.16100240000003)
Trp Met Cys Gly
C21H29N5O5S2 (495.16100240000003)
Trp Met Gly Cys
C21H29N5O5S2 (495.16100240000003)
Nikkomycin Z
C20H25N5O10 (495.16013499999997)
A uridine-based nucleoside-peptide antibiotic which inhibits fungal chitin biosynthesis by inhibiting chitin synthase. D000890 - Anti-Infective Agents > D000935 - Antifungal Agents D004791 - Enzyme Inhibitors
(2S)-2-[[(2S,3S,4S)-2-azaniumyl-4-hydroxy-4-(5-hydroxypyridin-2-yl)-3-methylbutanoyl]amino]-2-[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]acetate
C20H25N5O10 (495.16013499999997)
D000890 - Anti-Infective Agents > D000935 - Antifungal Agents D004791 - Enzyme Inhibitors
mycophenolic acid O-acyl-glucuronide(1-)
C23H27O12- (495.15024420000003)
A carbohydrate acid derivative anion that is the conjugate base of mycophenolic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.
(2R)-2-[[(2R,3R,4R)-2-amino-4-hydroxy-4-(5-hydroxy-2-pyridinyl)-3-methyl-1-oxobutyl]amino]-2-[(2S,3R,4S,5S)-5-(2,4-dioxo-1-pyrimidinyl)-3,4-dihydroxy-2-oxolanyl]acetic acid
C20H25N5O10 (495.16013499999997)
3-chloro-N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
C23H30ClN3O5S (495.1594600000001)
3-chloro-N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
C23H30ClN3O5S (495.1594600000001)
3-chloro-N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
C23H30ClN3O5S (495.1594600000001)
methyl (1S,9R,10R,11R)-10-(hydroxymethyl)-12-(2-methylphenyl)sulfonyl-6-oxo-5-pyridin-3-yl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylate
C25H25N3O6S (495.14639900000003)
3-chloro-N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
C23H30ClN3O5S (495.1594600000001)
3-chloro-N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
C23H30ClN3O5S (495.1594600000001)
2-chloro-N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
C23H30ClN3O5S (495.1594600000001)
2-chloro-N-[(5R,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
C23H30ClN3O5S (495.1594600000001)
2-chloro-N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
C23H30ClN3O5S (495.1594600000001)
4-chloro-N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
C23H30ClN3O5S (495.1594600000001)
4-chloro-N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
C23H30ClN3O5S (495.1594600000001)
methyl (1R,9S,10S,11S)-10-(hydroxymethyl)-12-(2-methylphenyl)sulfonyl-6-oxo-5-pyridin-3-yl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylate
C25H25N3O6S (495.14639900000003)
3-chloro-N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
C23H30ClN3O5S (495.1594600000001)
3-chloro-N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
C23H30ClN3O5S (495.1594600000001)
2-chloro-N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
C23H30ClN3O5S (495.1594600000001)
2-chloro-N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
C23H30ClN3O5S (495.1594600000001)
2-chloro-N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
C23H30ClN3O5S (495.1594600000001)
2-chloro-N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
C23H30ClN3O5S (495.1594600000001)
4-chloro-N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
C23H30ClN3O5S (495.1594600000001)
4-chloro-N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
C23H30ClN3O5S (495.1594600000001)
4-chloro-N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
C23H30ClN3O5S (495.1594600000001)
4-chloro-N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
C23H30ClN3O5S (495.1594600000001)
R 59-022 (hydrochloride)
C27H27ClFN3OS (495.15472940000006)
R 59-022 (DKGI-I) hydrochloride is a DGK inhibitor (IC50: 2.8 μM). R 59-022 hydrochloride inhibits the phosphorylation of OAG to OAPA. R 59-022 hydrochloride is a 5-HT Receptor antagonist, and activates protein kinase C (PKC). R 59-022 hydrochloride potentiates thrombin-induced diacylglycerol production in platelets and inhibits phosphatidic acid production in neutrophils[1][2][3][4].
(r)-{[(2s,3s,4s)-2-amino-1,4-dihydroxy-4-(5-hydroxypyridin-2-yl)-3-methylbutylidene]amino}[(2r,3s,4r,5r)-3,4-dihydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl]acetic acid
C20H25N5O10 (495.16013499999997)
(s)-{[(2s,3s,4s)-2-amino-1,4-dihydroxy-4-(5-hydroxypyridin-2-yl)-3-methylbutylidene]amino}[(2r,3s,4r,5r)-5-(4-formyl-2-hydroxyimidazol-1-yl)-3,4-dihydroxyoxolan-2-yl]acetic acid
C20H25N5O10 (495.16013499999997)
(s)-{[(2s,3s,4r)-2-amino-1,4-dihydroxy-4-(5-hydroxypyridin-2-yl)-3-methylbutylidene]amino}[(2r,3s,4r,5r)-3,4-dihydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl]acetic acid
C20H25N5O10 (495.16013499999997)